• @lightnsfw@reddthat.com
      link
      fedilink
      English
      41 month ago

      Might as well stop paying for fat people’s health care all together. They already know what the problem is.

      • @9point6@lemmy.world
        link
        fedilink
        English
        151 month ago

        Making fat people less fat means they live healthier lives and cost the healthcare system less.

        At least that’s what we think in countries where healthcare is ran for the good of its people and not for some shareholder’s profits.

        • MaineDPC
          link
          fedilink
          11 month ago

          Not necessarily. This is likely a good thing for patients but not a way to save money.

          • @thrawn@lemmy.world
            link
            fedilink
            English
            61 month ago

            No one’s explaining because it seems pretty obvious to most, but I’m gonna anyway in case you really don’t understand. It mostly comes down to your unusual preference towards the two most extreme options, which invalidates your entire premise, but I’ll get to that at the end of this.

            Let’s use the worst case scenario numbers for now. The report indicates that Ozempic costs ~$969 a month, a number I’ll use because it fits the analysis that, if 50% of obese Americans took it, it would be ~400bil a year. Don’t have more than 10min for this so I can’t promise that’s accurate, but a quick Google search seemed to agree.

            That’s about $11.7k a year. From what I can find, 2/3 people stop using it after about a year. Let’s go with 60 weeks, which is where weight loss seems to plateau. So around $13.5k per person.

            Thanks to the absurd cost of healthcare in the US, a single hospital stay for obesity related emergencies will cover a lot of years of Ozempic. But of course, this is the extreme case, and it doesn’t need to be this way.

            The report indicates that Ozempic is sold for less than 16% of the US price in virtually every other country. Let’s go with the next highest price, $155 (I assume USD as the others appear in $ as well) per month in Canada. That’s less than $1900 a year. A single hospital stay could cover dozens of people. Long term care for obesity or obesity related issues is also more than $1900 a year or $2200 for 60 months. This pricing is still profitable for Novo Nordisk, merely not extortionately so.

            Thus why your opinion is unpopular: you appear either too dull to consider a broader view, or cruel for saying that 70 million people should receive no healthcare. While the latter is both stupid and evil, it actually seems like people are assuming you lack the capacity of thought to have considered the numbers or read the report. Cruelty is too common on the internet so that one is more shocking, hence the very negative reactions. It’s easier to ignore a clear ass than someone blindingly narrowminded; even I couldn’t resist and I don’t engage with trolls or dicks.

            I only wrote this to explain why your comments come off as largely nonsensical, then why they are receiving such negative response. I won’t respond if you fight me on it, I haven’t actually given my opinion (you’ll note I only went and pulled numbers from the report) so there’s nothing to discuss

          • applepie
            link
            fedilink
            51 month ago

            A take somebody has with middle schooler’s understanding of how compex system function.

      • @Holyginz@lemmy.world
        link
        fedilink
        English
        51 month ago

        Ahh. Another fat phobic unempathetic asshole. Would be hilarious if you got punched in the face and when you went to the hospital they refused to treat you because obviously the solution would’ve been for you to not be an asshole.

  • @givesomefucks@lemmy.world
    link
    fedilink
    English
    361 month ago

    In the US, the estimated net price (after rebates) of Wegovy is $809 per month. In Denmark, the price is $186 per month. A study by researchers at Yale estimated that drugs like Wegovy can be profitably manufactured for less than $5 per month.

    Sounds like we already got the solution…

  • @reddig33@lemmy.world
    link
    fedilink
    English
    15
    edit-2
    1 month ago

    The savings from not having to pay treatment costs for as many arthritis, heart disease, stroke, fatty liver, and diabetes cases should balance the costs.

    Also most insurance companies refuse to cover semaglutide, so I don’t see this bankrupting anyone but the patients who pay out of pocket.

    • MaineDPC
      link
      fedilink
      11 month ago

      That’s a bold assumption. While prevention may be the right thing to do for patients’ sake, it rarely saves money. Last time I checked, very few preventive measures save money except for vaccines in children and young adults. Often, if we live longer , we develop more expensive long term diseases.

      • @BmeBenji@lemm.ee
        link
        fedilink
        English
        51 month ago

        When was the last time you checked? And where? And how deep in the sand was your head when you did so?

        • MaineDPC
          link
          fedilink
          11 month ago

          Within the last year. This is what I do for a living, I advise patients on preventive care every day. What’s in their interest differs from what saves money for the whole population though.
          You seem pretty sure I’m wrong based on your insult, where did you find evidence that it saves money?

    • @Mirshe@lemmy.world
      link
      fedilink
      English
      130 days ago

      Why can we, the literal richest country on Earth, not do both? Also, MOST VEGETABLES are already pretty heavily subsidized - crop subsidies make up a substantial portion of a lot of farmer’s earnings.